NIH Launches Trial of Rigel Drug for Severe COVID-19

    0
    50

    The U.S. National Institutes of Health on Thursday launched a clinical trial of fostamatinib, currently used to treat a blood platelet-destroying autoimmune disorder, in patients hospitalized with severe COVID-19, the disease caused by the novel coronavirus. The tablets,…

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here